APA (7th ed.) Citation

Lyden, P., Levy, H., Weymer, S., Pryor, K., Kramer, W., Griffin, J. H., . . . Zlokovic, B. (2013). Phase 1 safety, tolerability and pharmacokinetics of 3K3A-APC in healthy adult volunteers. Current pharmaceutical design, 19(42), 7479. https://doi.org/10.2174/1381612819666131230131454

Chicago Style (17th ed.) Citation

Lyden, Patrick, Howard Levy, Sara Weymer, Kent Pryor, William Kramer, John H. Griffin, Thomas P. Davis, and Berislav Zlokovic. "Phase 1 Safety, Tolerability and Pharmacokinetics of 3K3A-APC in Healthy Adult Volunteers." Current Pharmaceutical Design 19, no. 42 (2013): 7479. https://doi.org/10.2174/1381612819666131230131454.

MLA (9th ed.) Citation

Lyden, Patrick, et al. "Phase 1 Safety, Tolerability and Pharmacokinetics of 3K3A-APC in Healthy Adult Volunteers." Current Pharmaceutical Design, vol. 19, no. 42, 2013, p. 7479, https://doi.org/10.2174/1381612819666131230131454.